Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-23

Clinical Trial Update: Botox Injection in Treatment of Chronic Migraine [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Botox injections for chronic migraine has completed, as reported by the trial listing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Migraine Disorders | Phase 1, Phase 2 | Status: COMPLETED